Matthias Huber - Concepedia

Author

Matthias Huber

Charité - Universitätsmedizin Berlin

Also Known As

M Barbara Huber, M HUBER, M Huber, M. Barbara Huber, M. HUBER, M. Huber, Martin Huber, Matthias Huber

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin University Medical Center Hamburg-Eppendorf Leibniz Institute for Prevention Research and Epidemiology - BIPS University of Tübingen Centre National de la Recherche Scientifique

About

Matthias Huber is an author at Charité - Universitätsmedizin Berlin specializing in medicine, physiology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Natural Sciences	2	2	91
3	Public Health	2	2	74
4	Health Sciences	1	1	62
5	Anesthesia	1	1	762

Matthias Huber

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe Walid Habre, Nicola Disma, Katalin Virág, The Lancet Respiratory Medicine Patient SafetyPediatricsOutcomes ResearchPaediatric AnaesthesiaPediatric Surgery	2017	762
Evaluation of Variable-Dose Treatment with a New U.S. Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Michael A. C. Kane, Fredric S Brandt, Rod J. Rohrich, Plastic & Reconstructive Surgery	2009	130
Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris Alexander Nast, I. Kopp, Matthias Augustin, JDDG Journal der Deutschen Dermatologischen Gesellschaft	2007	94
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis Kirsten Siepmann, Matthias Huber, Nicole Stübiger, Graefe s Archive for Clinical and Experimental Ophthalmology Translational MedicineMycophenolate MofetilImmunosuppressive TherapyImmunologySafe Immunosuppressive Agent	2005	88
Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study Matthias Huber, Frank Andersohn, Giselle Sarganas, European Journal of Clinical Pharmacology MedicineHematologyPathologyMetamizole-induced Agranulocytosis	2014	87
Evidence for a Novel TGF-β1−Independent Mechanism of Fibronectin Production in Mesangial Cells Overexpressing Glucose Transporters Cora Weigert, Katrin Brodbeck, Frank C. Brosius, Diabetes Fibronectin ProductionJun ProteinsImmunologyCell GrowthCellular Physiology	2003	70
Large-scale mapping of mutations affecting zebrafish development Robert Geisler, Gerd-Jörg Rauch, Silke Geiger‐Rudolph, BMC Genomics	2007	67
Effects of varying dietary protein to lipid ratios on growth performance and body composition of juvenile pike perch (Sander lucioperca) Carsten Schulz, Matthias Huber, Johnny Ogunji, Aquaculture Nutrition NutritionJuvenile Pike PerchAquatic Food SystemBody CompositionFeed Additive	2007	62
Drug-induced agranulocytosis in the Berlin case–control surveillance study Matthias Huber, Frank Andersohn, Elisabeth Bronder, European Journal of Clinical Pharmacology Drug SafetyDrug InteractionsClinical EpidemiologyHematologyPharmacology	2013	53
Long-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines Ronald L. Moy, Corey S. Maas, Gary D. Monheit, Archives of Facial Plastic Surgery Microbial ToxinTreating Glabellar LinesToxinologyBioequivalenceMultiple Reloxin Treatments	2009	43

Page 1